In both normal and BCNS fibroblasts samples, upstream regulators CDKN1A and TP53 were activated whereas the E2F1 and RABL6 were predicted to be inhibited in response to rapamycin. Here, E2F1 is linked to nevoid basal cell carcinoma syndrome.